inhaled nebulized or aerosolized glutathione Advances in Nanoparticle Drug Delivery for Pulmonary Disease Management Inhaled glutathione decreases PGE2 and
Description
Although PD-L1 expression and the presence of TILs are reasonable markers, we are still far from obtaining strong predictive signatures for ICIs in TNBC
This difference in effect may be related to the energy metabolism status, oxidative stress level, inflammatory signaling pathways, and the upstream/downstream targets of SIRT1
Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
PCC, convalescent individuals with PCC
